Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CORE bioequivalence study of prednisolone and dexamethasone
NL-OMON24470Recruiting
- Sponsor
- N.A.
- Start
- Mar 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of prednisolone and dexamethasone (2 arms), sponsored by N.A. Primary endpoint: Difference in total cortisol excretion between prednisolone and dexamethasone at low and high doses. Started Mar 2021; status: recruiting.
02
Drugs
prednisolonedexamethasone
Beyond the preview
Go deeper on NL-OMON24470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24470.